Growth • Merck & Co
MRK
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
6,5%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
10,6%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
11,7%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
12,1%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
11,4%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
9,8%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!